Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
Public ClinicalTrials.gov record NCT00570752. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Randomized, Semi Double-Blinded Study Evaluating the Effects of Daily Oral High-Dose Atorvastatin or BMS-582949 on Atherosclerotic Plaque Inflammation as Determined by FDG-PET in High Risk Atherosclerotic Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine whether a p38 kinase inhibitor reduces inflammation in atherosclerotic plaque
Study identification
- NCT ID
- NCT00570752
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2008
- Primary completion
- Oct 31, 2010
- Completion
- Nov 30, 2010
- Last update posted
- Dec 6, 2015
2008 – 2010
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southeast Clinical Research, Llc | Chiefland | Florida | 32626 | — |
| Jacksonville Center For Clinical Research - Univ Campus | Jacksonville | Florida | 32216 | — |
| Florida Cardiovascular Institute | Tampa | Florida | 33609 | — |
| Phillip D. Toth, Md | Indianapolis | Indiana | 46260 | — |
| L-Marc Research Center | Louisville | Kentucky | 40213 | — |
| Commonwealth Biomedical Research, Llc | Madisonville | Kentucky | 42431 | — |
| Mgh Cardiac Mr Pet Ct Program | Boston | Massachusetts | 02114 | — |
| Troy Internal Medince Pc/Research | Troy | Michigan | 48098 | — |
| Radiant Research, Inc. | Edina | Minnesota | 55435 | — |
| Mount Sinai School Of Medicine Imaging Science Laboratories | New York | New York | 10029 | — |
| The Lipid Center | Statesville | North Carolina | 28677 | — |
| Metabolic And Atherosclerosis Research Center | Cincinnati | Ohio | 45212 | — |
| Sterling Research Group | Cincinnati | Ohio | 45219 | — |
| Hospital Of The University Of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Radiant Research, Inc. | Dallas | Texas | 75231 | — |
| Baylor College Of Medicine | Houston | Texas | 77030 | — |
| Mcallen Heart Clinic | McAllen | Texas | 78503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00570752, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00570752 live on ClinicalTrials.gov.